Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Jan 17, 2019
Anti-aging startup Juvenescence raises USD 46 Million Juvenescence has bagged the USD 46 million in series B financing. The investment tees the anti-ageing startup to progress the multi-asset pipeline. Jim Mellon, a British billionaire biotech investor, created Juvenescence with early Medivation backer Greg Bai...
Read More...
Dec 05, 2016
Obsessive-Compulsive Disorder (OCD) is the fourth most common psychiatric disorder, and a leading cause of disability which begins during adolescence age and remains as a lifelong illness. It is usually characterized by intrusive and reoccurring thoughts along with repetitive behaviors. It is usually under-diagnosed...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper